News
🇺🇸 FDA Page 9Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 97–108 of 807 articles
Rx Rundown: Pfizer, Hikma Pharmaceuticals, NewLimit — Drug Approvals & Catalyst Tracker
5 min
Dr. Sarah MitchellMIRA Pharma Consolidates Global Rights to MIRA-55 and SKNY-1
5 min
Dr. Sarah Mitchell4 Biotech Stocks Investors Should Watch in 2026: Market Analysis
4 min
Dr. Sarah MitchellAlabama Board of Medical Examiners Issues Warning on Non-FDA-Approved Peptides: What Pharma Teams Need to Know
FDA · 4 min
Dr. Sarah MitchellVertex Announces FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
FDA · IgA Nephropathy · 4 min
Dr. Sarah MitchellAurobindo Pharma OAI Classification: Implications for Drug Approvals
FDA · 5 min
Dr. Sarah MitchellLee, Tuberville Introduce Protections for Homeopathic Medicine with FDA Approval Framework
FDA · 4 min
Dr. Sarah MitchellDaraxonrasib Doubles Survival in Pancreatic Cancer: What Pharma Teams Need to Know
pancreatic cancer · 4 min
Dr. Sarah MitchellFDA Approves Ensitrelvir (XOCOVA) as First Oral Option for COVID-19 Post-Exposure Prophylaxis
FDA · COVID-19 · 5 min
Dr. Sarah MitchellGeneric Drugmakers Gain Key Victory in ‘Skinny Label’ Patent Case
US Supreme Court · 5 min
Dr. Sarah MitchellTexas AG Investigating Energy Drinks: What Pharma Teams Need to Know
FDA · 5 min
Dr. Sarah MitchellFDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer
FDA · oncology · 5 min
Dr. Sarah MitchellPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways